Trial Profile
Short Term Effect of Liraglutide Versus Vildagliptine on Insulin Secretion and Insulin Sensitivity in a Sub Saharan African Population With Type 2 Diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 06 Nov 2021
Price :
$35
*
At a glance
- Drugs Liraglutide (Primary) ; Vildagliptin
- Indications Type 2 diabetes mellitus
- Focus Therapeutic Use
- Acronyms LIRAVIS
- 21 Dec 2017 Status changed from recruiting to completed.
- 19 Jul 2016 New trial record